drugset
drugset / Trial / NCT05638347

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

NCT05638347 ↗

Phase 1 Completed 16 enrolled Atridia Pty Ltd.
RandomizedSequentialDouble-blindTreatment

Summary

The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of HRS-7085.

Timeline

Start
2022-12-05
Primary completion
2023-03-16
Completion
2023-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-7085 Unknown — Oral

Indications

inflammatory bowel disease